Key result
Stable CAD and PAD link to decreased fibrinolysis while AMI shows increased coagulation versus healthy controls.
Why the study?
Hypercoagulability is a major determinant of atherosclerosis, but differences between diverse atherosclerotic cardiovascular disease presentations remain understudied.
Do hemostatic profiles differ between apparently healthy individuals and patients with different presentations of atherosclerotic cardiovascular disease (stable CAD, PAD, or recent AMI)?
Population
436 individuals, including healthy controls, stable CAD, post-MI, and PAD patients
Comparison
Hemostasis across healthy individuals, stable CAD, symptomatic PAD, and post-MI
Design
Cross-sectional study
Authors
Loading...
Does not support routine hemostatic testing in ASCVD; leaves open targeted antithrombotic trials in high-OHP subgroups.
Cross-Sectional (n=436)
Do hemostatic profiles differ between apparently healthy individuals and patients with different presentations of atherosclerotic cardiovascular disease (stable CAD, PAD, or recent AMI)?
Different presentations of atherosclerotic cardiovascular disease are associated with distinct hemostatic imbalances, highlighting specific prothrombotic mechanisms in stable CAD, PAD, and recent AMI.
Kosuta et al. (2026) conducted a cross-sectional in Atherosclerotic cardiovascular disease (ASCVD) (n=436). Atherosclerotic cardiovascular disease presentations (stable CAD, PAD, AMI) vs. Apparently healthy individuals was evaluated on Hemostasis measurements (Overall hemostatic potential, overall coagulation potential, overall fibrinolytic potential). Compared to healthy individuals, patients with stable CAD and PAD exhibited decreased fibrinolysis, whereas patients after AMI showed increased coagulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: